A tumultuous year for gene therapy.
Verma
I M
IM
D000256:Adenoviridae / Q000235:genetics; D000293:Adolescent; D002986:Clinical Trials as Topic / Q000592:standards*; D015316:Genetic Therapy / Q000592:standards*; D005822:Genetic Vectors / Q000009:adverse effects; D006801:Humans; D008297:Male; D009316:National Institutes of Health (U.S.); D014481:United States; D014486:United States Food and Drug Administration